Is Mesa Laboratories (MLAB) a Growing Stock?
Andvari Associates, an investment management company, released its fourth-quarter 2022 investor letter. A copy of the same can be downloaded here.
Mesa Laboratories Inc (MLAB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 251,180 | $35,374 | -10% | 0.4% |
| 2. | 24,388,000 | $20,334 | +32% | 0.78% | |
| 3. | 15,000,000 | $12,607 | 0.23% | ||
| 4. | 14,000,000 | $12,128 | 0.17% | ||
| 5. | Point72 Asset Management Steve Cohen | 36,159 | $5,092 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $200.00 | 500 | Director | 500 | 2022-08-09 | Filing | |
| $0.00 | 0 | Director | 43,016 | 2019-03-31 | Filing | |
| $29.00 | 10,000 | Director, Other | 200,000 | 2011-03-03 | Filing | |
| $24.75 | 40,000 | Director, Other | 190,000 | 2010-12-21 | Filing | |
| $21.52 | 30,000 | Director, Other | 150,000 | 2010-10-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $210.19 | 2,100 | Officer | 9,696 | 2023-01-23 | Filing | |
| $191.31 | 1,571 | Director | 68,976 | 2023-01-13 | Filing | |
| $191.31 | 1,571 | Director | 68,976 | 2023-01-13 | Filing | |
| $174.98 | 230 | Director | 957 | 2022-12-08 | Filing | |
| $175.45 | 2,500 | Director | 68,976 | 2022-11-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 574,783 | $95,534,682 | 1.78% | |
| 2. | 10,000,000 | $9,099,309 | 0.09% | |
| 3. | 5,000,000 | $4,522,550 | 0.02% | |
| 4. | 14,275 | $2,372,648 | 0.13% | |
| 5. | 11,438 | $1,901,110 | 0.38% |
News See All
Here's Why Mesa Laboratories (MLAB) Declined in Q3
Conestoga Capital Advisors, an asset management company, released its “Small Cap Growth Fund” third-quarter investor letter. A copy of the same can be downloaded here.
10 Best Small Cap Stocks to Buy in 2021
In this article we will take a look at the 10 best small cap stocks to buy in 2021.
Is MLAB A Good Stock To Buy Now?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Hedge Funds Aren't Crazy About Mesa Laboratories, Inc. (MLAB) Anymore
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Was The Smart Money Right About Mesa Laboratories, Inc. (MLAB)?
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds.
Is Mesa Laboratories, Inc. (MLAB) A Good Stock To Buy ?
The market has been volatile in the last few months as the Federal Reserve finalized its rate cuts and uncertainty looms over trade negotiations with China.
Hedge Funds Are Dumping Mesa Laboratories, Inc. (MLAB)
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Have Never Been More Bullish On Mesa Laboratories, Inc. (MLAB)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of March.
Is Mesa Laboratories, Inc. (MLAB) A Good Stock To Buy?
"Value has performed relatively poorly since the 2017 shift, but we believe challenges to the S&P 500’s dominance are mounting and resulting active opportunities away from the index are growing.
Billionaire Hedge Funds
